Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.

Arthritis Rheumatol · 2020 · PMC6972605 · PMID 31469249

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

approached significanceP = 0.052so close (0.05 < p ≤ 0.1)

The presence of historical anti‐Sm antibodies approached significance ( P = 0.052) (Figure 2 B).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.